Elite Pharmaceuticals, Inc. (ELTP)
0.3599
-0.03
(-8.45%)
USD |
OTCM |
Feb 20, 16:00
Elite Pharmaceuticals Total Liabilities (Quarterly) : 46.10M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Glaukos Corp. | 237.33M |
| cbdMD, Inc. | 2.774M |
| ACADIA Pharmaceuticals, Inc. | 413.50M |
| Alnylam Pharmaceuticals, Inc. | 4.236B |
| Savara, Inc. | 46.54M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 126.41M |
| Shareholders Equity (Quarterly) | 80.31M |
| Debt to Equity Ratio | 0.0754 |
| Current Ratio | 7.340 |
| Net Debt Paydown Yield | 0.20% |